Dial-in Number

  • One tap mobile
    +13126266799,,3231998494# US (Chicago)
    +13462487799,,3231998494# US (Houston)
  • Dial by your location
    +1 312 626 6799 US (Chicago)
    +1 346 248 7799 US (Houston)
    +1 669 900 6833 US (San Jose)
    +1 929 436 2866 US (New York)
    +1 253 215 8782 US
    +1 301 715 8592 US
    Meeting ID: 323 199 8494
    Find your local number:

Web session

HL7 Antitrust Policy

Professional Associations, such as HL7, which bring together competing entities are subject to strict scrutiny under applicable antitrust laws. HL7 recognizes that the antitrust laws were enacted to promote fairness in competition and, as such, supports laws against monopoly and restraints of trade and their enforcement. Each individual participating in HL7 meetings and conferences, regardless of venue, is responsible for knowing the contents of and adhering to the HL7 Antitrust Policy as stated in §05.01 of the Governance and Operations Manual (GOM).


Danielle Bancroft (Chair)Best Practice Software
Melva PetersJenaker Consulting
John Hatem (Scribe)Independent Consultant
Margaret WeikerNCPDP
Christof GessnerHL7 Germany
Peter SergentHL7 New Zealand
Stephen ChuAustralian Digital Health Agency (ADHA)
Scott RobertsonKaiser Permanente
Corey SpearsMitre
Jean DuteauDuteau Design
Shelly SpiroPharmacy HIT Collaborative
Dave HillMITRE
Frank McKinneyPOCP

Agenda Items and Notes

Meeting Notes from previous meeting

Project Review

Project Proposals

Project Scope Statements

Discussion of MedicationKnowledge changes (Jean Duteau)

  • - no updates today

Catalog Updates (John Hatem)

  • - no pharmacy specific issues discussed but these topics were on the agenda
    • plan is to release next Catalog IG update in May.  Need to follow-up and confirm if this is expected to include Pharmacy catalog
    • they have removed the CatalogEntry resource
    • they have made 3 suggested changes to ClinicalUseDefinition resource, all of which were accepted.
    • they also have been working on Device Definition issues - unrelated to Pharmacy
    • Next meeting will be November 19, 2021

Workflow Update (John Hatem) 

  • - no meeting this week

Healthcare Product Update (John Hatem)

  • -  reported that Pharmacy will use the Device to parent Device relationship, where Device will be used to represent the Port/lumen e.g. distal; and parent Device will be used to represent the triple lumen catheter.  I have three outstanding questions back to O&O:
  1. What element in Device should we use to specify the port/lumen?
  2. What element in Device should we use to specify the triple lumen catheter?
  3. If we needed to specify the gauge of the lumen/port, which element in Device would we use?  and which resource should we do this in?  the Device where the port/lumen is specified, or in the parent Device?

NCPDP Updates (NCPDP Members)

  • No updates. NCPDP WG Meetings were held last week. Most Task Group Meetings will resume the week of November 15th.

Global Supply Chain Project (Scott)

Medication List Guidance project (John)

  • - no updates this past week


Pharmacy Templates

PDex Formulary (Corey)

FHIR (Group)

BR&R managed resources review

New Resource - FormularyItem

Preparation for Normative

Trackers - link to pharmacy unresolved Jira trackers (see trackers for details / resolutions)

  • 34195 : motion by Melva,seconded by Scott R. Motion passed 11-0-0
  • 34218: 

Any Other Business

Next meeting

  • November 15, 2021